HomePfizer’s $11.6 billion Biohaven buy could spark more biotech dealsFILE PHOTO: Biohaven Pharmaceutical Holding Company logo is displayed on

FILE PHOTO: Biohaven Pharmaceutical Holding Company logo is displayed on

FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company's IPO on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 4, 2017. REUTERS/Brendan McDermid/File Photo

FILE PHOTO: A person walks past the Pfizer Headquarters building

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

August 3, 2023

For investors, green companies still hard to find with new emissions reporting rules

August 3, 2023

Pope, in Portugal to rally young Catholics, says Church needs purification

August 3, 2023

Wall Street ends down, investors step back after Fitch US rating cut

August 2, 2023

FILE PHOTO: Biohaven Pharmaceutical Holding Company logo is displayed on

Most Read

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

Wall Street ends down, investors step back after Fitch US rating cut

EDITOR PICKS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR POSTS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR CATEGORY